|Published (Last):||3 November 2004|
|PDF File Size:||7.46 Mb|
|ePub File Size:||4.76 Mb|
|Price:||Free* [*Free Regsitration Required]|
The EverFlex self-expanding stent system is a nitinol stent system that expands to a predetermined diameter to re-open narrowed stenotic regions of the SFA and proximal popliteal arteries that supply blood to the legs. Narrowing of these arteries is associated with a condition known as peripheral arterial disease PAD , where plaque builds along the lining of the arteries, blocking blood flow to the legs.
Krishna J. The mean lesion length was 8. Subjects were followed annually for three years with independent ultrasound core lab adjudicated duplex ultrasound to determine stent patency, radiograms of the stented extremity to assess stent fractures and ankle brachial indices.
Duplex ultrasound-assessed patency PSVR 8 cm at The three year freedom from target lesion revascularization TLR was 70 percent. The three-year stent fracture rate was 0. The company strives to offer products and services that deliver clinical and economic value to healthcare consumers and providers worldwide. About Medtronic Medtronic plc www. Actual results may differ materially from anticipated results.
VeriFLEX Stent System
EverFlex Self-expanding Peripheral Stent with Entrust Delivery System